Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial
- PMID: 20236788
- PMCID: PMC2947952
- DOI: 10.1016/j.jacc.2010.03.002
Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial
Abstract
Objectives: The purpose of this study was to determine whether smoking cessation improves flow-mediated dilation (FMD) of the brachial artery.
Background: The long-term effects of continued smoking and smoking cessation on endothelial function have not been described previously.
Methods: This was a 1-year, prospective, double-blind, randomized, placebo-controlled clinical trial of the effects of 5 smoking cessation pharmacotherapies. FMD was measured by B-mode ultrasonography before and 1 year after the target smoking cessation date. Cessation was verified by exhaled carbon monoxide levels. DeltaFMD was compared among study arms and between subjects who successfully quit smoking and those who continued to smoke. Predictors of baseline FMD and DeltaFMD were identified by multivariable regression.
Results: The 1,504 current smokers (58% female, 84% white) were 44.7 +/- 11.1 years of age and smoked 21.4 +/- 8.9 cigarettes/day. Baseline FMD was similar in each treatment arm (p = 0.499) and was predicted by BA diameter (p < 0.001), reactive hyperemia blood flow (p < 0.001), high-density lipoprotein cholesterol (p = 0.001), and carbon monoxide (p = 0.012) levels. After 1 year, 36.2% quit smoking. FMD increased by 1% (6.2 +/- 4.4% to 7.2 +/- 4.2%) after 1 year (p = 0.005) in those who quit, but did not change (p = 0.643) in those who continued to smoke. Improved FMD among quitters remained significant (p = 0.010) after controlling for changes in brachial artery diameter, reactive hyperemia, low-density lipoprotein cholesterol, and the presence of a home smoking ban.
Conclusions: Despite weight gain, smoking cessation leads to prolonged improvements in endothelial function, which may mediate part of the reduced cardiovascular disease risk observed after smoking cessation. (Smoking Cessation Medications: Efficacy, Mechanisms and Algorithms; NCT00332644).
Copyright 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Smoking is associated with dose-related increase of intima-media thickness and endothelial dysfunction.Angiology. 1999 Mar;50(3):201-8. doi: 10.1177/000331979905000304. Angiology. 1999. PMID: 10088799
-
Effects of vitamin E on chronic and acute endothelial dysfunction in smokers.J Am Coll Cardiol. 2000 Feb;35(2):277-83. doi: 10.1016/s0735-1097(99)00542-2. J Am Coll Cardiol. 2000. PMID: 10676670 Clinical Trial.
-
Effects of smoking cessation on endothelial function as assessed by flow-mediated total dilation.Cardiovasc Ultrasound. 2024 Aug 14;22(1):11. doi: 10.1186/s12947-024-00329-9. Cardiovasc Ultrasound. 2024. PMID: 39143500 Free PMC article.
-
The association between smoking exposure and endothelial function evaluated using flow-mediated dilation values: a meta-analysis.BMC Cardiovasc Disord. 2024 Jun 5;24(1):292. doi: 10.1186/s12872-024-03915-x. BMC Cardiovasc Disord. 2024. PMID: 38840064 Free PMC article.
-
Motivational support intervention to reduce smoking and increase physical activity in smokers not ready to quit: the TARS RCT.Health Technol Assess. 2023 Mar;27(4):1-277. doi: 10.3310/KLTG1447. Health Technol Assess. 2023. PMID: 37022933 Free PMC article.
Cited by
-
Smoking cessation can improve quality of life among COPD patients: validation of the clinical COPD questionnaire into Greek.BMC Pulm Med. 2011 Feb 25;11:13. doi: 10.1186/1471-2466-11-13. BMC Pulm Med. 2011. PMID: 21352544 Free PMC article.
-
Noninvasive assessment of vascular structure and function in conscious rats based on in vivo imaging of the albino iris.Am J Physiol Regul Integr Comp Physiol. 2011 Jun;300(6):R1333-43. doi: 10.1152/ajpregu.00561.2010. Epub 2011 Mar 9. Am J Physiol Regul Integr Comp Physiol. 2011. PMID: 21389331 Free PMC article.
-
Endothelial dysfunction and coronary artery disease: assessment, prognosis, and treatment.Coron Artery Dis. 2014 Dec;25(8):713-24. doi: 10.1097/MCA.0000000000000178. Coron Artery Dis. 2014. PMID: 25365643 Free PMC article. Review.
-
Inflammatory Mechanisms Contributing to Endothelial Dysfunction.Biomedicines. 2021 Jul 6;9(7):781. doi: 10.3390/biomedicines9070781. Biomedicines. 2021. PMID: 34356845 Free PMC article. Review.
-
Relationship of cigarette smoking with inflammation and subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis.Arterioscler Thromb Vasc Biol. 2015 Apr;35(4):1002-10. doi: 10.1161/ATVBAHA.114.304960. Epub 2015 Mar 5. Arterioscler Thromb Vasc Biol. 2015. PMID: 25745060 Free PMC article.
References
-
- Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association. Circulation. 2010;121:e46–e215. - PubMed
-
- Freund KM, Belanger AJ, D'Agostino RB, Kannel WB. The health risks of smoking. The Framingham Study: 34 years of follow-up. Ann Epidemiol. 1993;3:417–24. - PubMed
-
- Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol. 2004;43:1731–7. - PubMed
-
- Benowitz NL. Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment. Prog Cardiovasc Dis. 2003;46:91–111. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases